Results 251 to 260 of about 1,946,862 (417)

HeLa genome versus donor's genome [PDF]

Nature, 2013
openaire   +3 more sources

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Correction: Genomic analyses revealed low genetic variation In the Intron-exon boundary of the doublesex gene within the natural populations of An. gambiae s.l. in Burkina Faso. [PDF]

BMC Genomics
Kientega M, Morianou I, Traoré N, Kranjc N, Kaboré H, Zongo ON, Millogo AA, Epopa PS, Yao FA, Belem AMG, Burt A, Diabaté A.   +11 more
europepmc   +1 more source

Characterization and functional expression in mammalian cells of genomic and cDNA clones encoding a Drosophila muscarinic acetylcholine receptor.

, 1989
Robert A. Shapiro, Barbara T. Wakimoto, E M Subers, Neil M. Nathanson   +3 more
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Editorial for the special collection: frontiers in rare disease genetics. [PDF]

Genomics Inform
Choi M.
europepmc   +1 more source

Harnessing the power of RADseq for ecological and evolutionary genomics

Nature reviews genetics, 2016
Kimberly R. Andrews, J. Good, Michael R. Miller, G. Luikart, Paul A Hohenlohe   +4 more
semanticscholar   +1 more source

INTROGRESSION BETWEEN TWO CUTTHROAT TROUT SUBSPECIES WITH SUBSTANTIAL KARYOTYPIC, NUCLEAR AND MITOCHONDRIAL GENOMIC DIVERGENCE

, 1985
Ulf Gyllensten, Robb F. Leary, Fred W. Allendorf, Allan C. Wilson   +3 more
openalex   +2 more sources

Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-chromosome-linked ichthyosis. [PDF]

, 1987
Andrea Ballabio, Giancarlo Parenti, Rosalba Carrozzo, Gianfranco Sebastio, Generoso Andria, Veronica J. Buckle, Niall J. Fraser, Ian Craig, Mariano Rocchi, G. Cara Romeo   +9 more
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source